Clinical Trials Logo

Systemic Mast Cell Activation clinical trials

View clinical trials related to Systemic Mast Cell Activation.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04811365 Completed - Clinical trials for Systemic Mast Cell Activation

(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation

Start date: June 29, 2021
Phase:
Study type: Observational

This is a multi-center screening study with the primary objective to determine the prevalence of KIT D816V mutation in peripheral blood in patients with evidence of systemic mast cell activation (MCA).